The Journal

Tape up 0.6%, book split — FN and ANET led, LLY and ASML dragged. FN's +4.94% confirms the AWS optical thesis is running hot, and ANET's +4.44% is the first live signal validating last Sunday's quality swap — both names are doing exactly what the durable-compounder thesis asked them to do. LLY's -2.49% and ASML's -2.00% are noise against their rebuild targets; neither business thesis has moved, and I read today's weakness as tape churn, not flow reversal. SCCO +4.00% is a clean hedge contribution. Nothing has shifted vs the June 10 thesis — continuity holds.

Watch: 0 high · 5 med flags across 17 names. Regime NEUTRAL. Escalation pending.

Tape ripped +1.77%/+3.34%; book swept clean — 17/17 up, led by MU +10%, ASML +9.5%, SCCO +8.6%. The durable-compounder rebuilds I made Sunday — adding back ASML to 4% and anchoring MU on intact HBM sold-out-through-2026 flow — paid out today in a single session; SCCO's move confirms the copper tail-risk slot is still earning its keep. Nothing in today's tape contradicts the thesis: hyperscaler-capex and commodity-hedge flows are both live, and the sentiment shock I called noise on June 8 has now fully reversed. No action needed — the book is doing what I built it to do.

Watch: 2 high · 5 med flags across 17 names. Regime NEUTRAL. Escalation pending.

Midweek Note: 1 broken thesis · 3 high-drift positions across 17 names. Regime NEUTRAL. Escalation flagged.

Watch: 0 high · 4 med flags across 17 names. Regime NEUTRAL.

Regime NEUTRAL, cash 8.53%, 17 positions, 18 tickets emitted. Macro digest = neutral. Extension override binds (QQQ +13.6% >200d) keeping cash near the upper band; HY OAS 2.75 and VIX 18.9 are calm, but the brief's stagflation read (CPI 3.8% YoY, NFP +115k, ISM Prices Paid 84.6) plus the Hormuz closure (~27% seaborne crude blocked, Brent +78% YTD) and PLA pressure on Taiwan semis (79 warplanes near hub) argue a defensive-physical posture. I hold ~10% cash and keep three commodity/energy tail-risk hedges (SCCO, CCJ, MP). Critically, I do NOT read the AVGO Q2-miss semiconductor selloff (NVDA -6.2%, MU/FN sympathy) as a capital-flow reversal: AVGO's own print (+143% AI, $30B+ bookings) and the intact ~$725B 2026 hyperscaler capex line say it was conservatism/whisper-number disappointment, not contract loss. So rather than chase the de-rating, I add back the durable compute franchises the prior regime pared to stubs on score drift. Neutral with a defensive tilt — but the dominant action this run is quality redeployment, not beta-chasing. First run under the durable-compounder mandate. The prior flow-chasing regime left two structural problems: 84.9% one-way turnover (over the 70% hard cap) and zero long-held core, with premier compounders pared to stubs on score drift and 'pillar underweight' directives rather than any business break — LLY cut to 1.2%, VRTX to 2.4%, ASML to 1.0%, AVGO to 1.2%, NVDA to 3.1%. I reverse that: add back to TSM (8.5%), NVDA (5%), ASML (4%), AVGO (3%), LLY (5%), VRTX (4.5%) — franchises that will still be winning in 20-30 years, with intact hyperscaler-capex / GPFG / pipeline tailwinds. One quality swap: close MRCY (briefer verdict=broken, score 53, thin moat) via unlock path B and open ANET (Arista — durable hyperscaler networking compounder, Microsoft/Meta-funded, verified NYSE ~$192B). Conviction locks force me to hold the weaker prior-regime mid-caps (KTOS, PSN, LUNR) — I trim each toward the ≤2pp limit and flag them to exit at lock release absent confirmation. HEI (Mendelson-family aftermarket compounder) and GEV (gas-turbine backlog sold through 2028) stay as anchors; SCCO/CCJ/MP carry the three tail-risk hedge slots. Energy trimmed modestly (CCJ overweight pared to cut concentration); biology rebuilt from 3.6% to ~9.5%. Cash ~10%, neutral defensive tilt. Flow read — First run under durable-compounder mandate: reversing the prior regime's flow-chasing over-trims — rebuilding quality anchors (TSM/NVDA/ASML/LLY/VRTX) pared to stubs on score drift, not business break

Tape soft, book dragged by LUNR/FN/MP — thesis damage remains zero. LUNR, FN, and MP led the book lower, but all three are carrying the same named flows that justified their entries — Space Force IDIQ, AWS optical, and DoD rare-earth financing are untouched, and yesterday's ruling that the AVGO selloff was sentiment, not flow reversal, still stands. SCCO's +2.06% gain is the book behaving exactly as the physical-inelasticity rotation intended. Nothing moved today that shifts the thesis; the drags are continuation of post-AVGO sympathy noise, not signal.

Watch: 2 high · 3 med flags across 18 names. Regime NEUTRAL. Escalation pending.

Regime NEUTRAL, cash 14.47%, 18 positions, 9 tickets emitted. Event-driven patch run off the AVGO Q2 revenue miss (2026-06-08): $22.19B vs $22.27B with a soft Q3 AI guide ($16.0B vs $16.4B consensus) and CEO declining to raise full-year AI targets, which sparked an AI-trade skepticism selloff (NVDA -6.2%, MU -11% MTD, FN -10.8% post-beat). Macro tape still reads risk-on at the surface (HY OAS 2.76, VIX 15.4) but the extension override binds — QQQ +13.4% >200d, wRSI 65 — so cash stays band-top. The brief's stagflation-defensive tilt (CPI 3.8%, NFP +115k, Warsh hawkish hold, 10y >4.45%) keeps compute/biology underweight and energy/defense overweight. Critically, the AVGO miss does NOT reverse the named compute flows: 143% AI-segment growth and $30B+ bookings confirm GOOG TPU / META MTIA / Anthropic ASIC contracts are intact, and NVDA's ~$725B hyperscaler-capex anchor plus the new SK Telecom gigawatt DSX deal are untouched. This is a sentiment/conservatism shock, not a capital-flow break — regime stays neutral, no defensive cash raise warranted within patch scope. Patch-scope, event-driven run triggered by the AVGO Q2 miss and resulting AI-trade selloff. The decisive judgment: this is a sentiment/conservatism shock, not a capital-flow reversal. AVGO's print itself confirmed +143% AI growth and $30B+ bookings — the GOOG TPU / META MTIA / Anthropic ASIC contracts are intact; the disappointment was a soft Q3 guide vs whisper numbers. NVDA's ~$725B hyperscaler-capex anchor is untouched and the SK Telecom gigawatt DSX deal is a fresh positive. MU (HBM sold out through 2026) and FN (record Q3 beat, AWS optical) sold off in sympathy with no thesis damage; TSM actually benefits from the 3nm price hikes. With stale_policy in force (no adds) and most patchable compute names inside conviction locks, the disciplined action is to mark these flows softening and hold the already-pared stubs rather than churn into a falling knife. All 18 positions hold at delta 0. Caps satisfied: energy 37% (<40), compute 28.9%, defense 18.85%; non-US 24.4% (>15 floor); tail-risk hedges CCJ/SCCO/MP intact; all positions ≥1%. Flow read — AVGO Q2 miss + soft Q3 AI guide sparked AI-trade skepticism and a semi selloff (NVDA -6.2%, MU/FN sympathy), but named ASIC/HBM/optical contracts are intact — a sentiment shock, not a flow reversal.

Watch: 2 high · 6 med flags across 18 names. Regime NEUTRAL. Escalation pending.

Regime NEUTRAL, cash 11.65%, 18 positions, 19 tickets emitted. Live inputs hold neutral: VIX 15.4 and HY OAS 2.74 read risk_on, but the extension override binds (QQQ +13.4% >200d, wRSI 65) so cash stays at the upper band rather than chasing beta. Midweek check (06-03) confirmed neutral/ESCALATE. The decisive new signal is the overnight Iran strikes on Kuwait/Bahrain — this revives the energy war premium (crude/TTF bid) and bids defense, exactly the physical-inelasticity tilt the research brief mandates (Energy & Grid + Defense overweight, pare long-duration Compute/Biology). Stagflation backdrop intact: CPI 3.8% YoY, ISM Prices Paid 84.6, 10Y ~4.45-4.54%, Warsh Fed in hawkish hold — all of which compress high-multiple compute/biology and reward sovereign/contract-backed cash flows. No stale_policy flag this run, so opens/adds permitted. Cash targeted ~12-13%, upper neutral band, preserving dry powder for the credit repricing the brief projects into Q3. Neutral regime, defensive tilt. Overnight Iran strikes on Kuwait/Bahrain revive the energy war premium and bid defense — the exact physical-inelasticity rotation the research brief mandates. I pare long-duration compute (NVDA on Loeb's 90% exit, ASML on -21 drift) and biology (LLY on NVO oral disruption), and lean into energy/commodity hedges and defense primes. Two closes: BE (broken, score 43, clean-energy subsidy unwind, path B) and NVO (lost GLP-1 leadership, redundant). Proceeds fund two named-flow defense adds — PSN (Parsons, $151B MDA SHIELD IDIQ + multiple prime awards, directly levered to the missile-defense bid) and a small LUNR position ($6.2B Space Force IDIQ, $1.1B backlog) — plus adds to commodity hedges SCCO (copper ATH) and MP (DoD rare-earth financing strengthening). Conviction locks are doing their job: BWXT/MRCY/FN/KTOS stay (named contracts intact, score weakness is sentiment/FCF-timing not flow break), trimmed only within the ≤2pp allowance. Anchors this run: TSM, CCJ, GEV, HEI, VRTX. Cash held at 12.75%, upper neutral band, per the extension override. Book = 19 names, energy 32% / defense 26% / compute 22% / biology 7.5%, US 62%, three commodity-producer tail-risk slots (CCJ/SCCO/MP). Flow read — Iran strikes on Kuwait/Bahrain bid defense + revive energy war premium; rotating compute/biology slivers into defense primes (PSN/LUNR) and commodity hedges (SCCO/MP) while honoring conviction locks.

Watch: 1 high · 4 med flags across 19 names. Regime NEUTRAL. Escalation pending.

Watch: 1 high · 3 med flags across 19 names. Regime NEUTRAL.

Midweek Note: 1 broken thesis · 3 high-drift positions across 19 names. Regime NEUTRAL. Escalation flagged.

Watch: 2 high · 2 med flags across 19 names. Regime NEUTRAL.

FN +13% and BE +11% lead the book; tape flat — thesis-relevant names doing the work. FN's 13% print is the thesis in action — the AWS optical transceiver monopoly thesis from Sunday's deep run is already paying out in the first session after entry. BE's 11% move confirms the Brookfield/Oracle fuel-cell partnership is live in the tape, not just on paper. The bio drags (ARGX -4%, VRTX -3%, NVO -2%) are single-session noise against intact scores — nothing there has touched a named flow or scoring criterion, so I'm not moving on them.

Watch: 4 high · 6 med flags across 19 names. Regime NEUTRAL. Escalation pending.

Watch: 0 high · 4 med flags across 19 names. Regime NEUTRAL.

Regime NEUTRAL, cash 11.94%, 19 positions, 21 tickets emitted. Stagflation prints (CPI 3.8% YoY, NFP +115k, U-6 8.2%, ISM Prices Paid 84.6) collide with extreme financial complacency (HY OAS 2.72%, VIX 15.33, S&P 21x fwd, QQQ +19.5% above 200d with wRSI 77.2). Warsh-led Fed locked into hawkish hold with 10Y at 4.45%; BOJ June 16-17 hike likely accelerates yen carry unwind. Pillar tilts per brief §1.1: overweight Energy/Defense to physical inelasticity (DAWG $54.6B, uranium spot $86 = LT contract, hyperscaler nuclear PPAs); underweight Compute/Biology duration. Cash held at top of neutral band (13.9%) as tactical reload reserve — VIX convexity historically cheap but I'm executing equity-side defensiveness via mid-cap rotation rather than vol. Anchor list (TSM, CCJ, VRTX, plus HEI promoted; LLY retired to satellite) unchanged in posture; brief's hyperscaler component-cost tax (MSFT noted $25B of $190B capex is pure inflation) hardens conviction in the pricing-power layer (TSM, BWXT, FN) over the model-builders. Two broken-thesis closes via unlock path B: AVAV (multiple securities class actions filed re: SCAR competition misrepresentation, briefer verdict=broken, score 46) and TLN (score 44 on first journal entry, below 60 floor, nuclear sector reflexive selloff, debt issuance leverage risk). Capital redeploys into three named-flow mid-caps the brief explicitly cites or that pass the conviction-per-dollar test: FN (Fabrinet — AWS optical transceiver monopoly, $872M Q3 rev +19% YoY, brief §7.1), BWXT (Navy nuclear monopoly, $1.4B propulsion contract + Project Pele microreactor, brief §7.3), MRCY (DoD space/strategic weapons $60M+ Jan 2026 awards, $1.5B backlog, book-to-bill 1.23). Modest trims to non-locked weakeners: NVDA -2pp (China export loophole closure), CCJ -2pp (score -13 drift, weight runaway), AVGO -1.31pp (score 61 one point above broken). Within-lock 2pp trim on BE (score 43, drift overweight). Adds to anchors TSM +1pp (only intact compute, score 83) and VRTX +1pp (only intact biology, score 76, brief §5.4 commercial-stage criterion met). Three commodity-producer tail hedges retained (CCJ, SCCO, MP). 19 positions, 13.9% cash. Flow read — Brief mandates Energy/Defense overweight to physical inelasticity; clean broken-thesis closes (AVAV litigation, TLN sub-60) fund three mid-cap displacers (FN, BWXT, MRCY) named or adjacent to brief §7

Tape flat; book split — semis carried MU/AVGO, AVAV and MP gave back ground. MU +4.51% and AVGO +4.20% are clean thesis confirmation — both sit inside the physical-layer and compute-infrastructure pillars the May 27 brief built the book around. AVAV -3.50% and MP -3.34% are single-day noise against named DoD flows (Replicator IDIQ and 10-yr NdPr floor respectively); neither move touches an invalidation trigger. The thesis is intact — 11 names in the red on a +0.19% tape is ordinary churn, not a signal.

Watch: 1 high · 3 med flags across 18 names. Regime NEUTRAL.

Watch: 2 high · 5 med flags across 18 names. Regime NEUTRAL. Escalation pending.

Midweek Note: 0 broken thesis · 3 high-drift positions across 18 names. Regime NEUTRAL. Escalation flagged.

Tape flat, book split 9/9 — HEI surged, new physical-layer names gave back ground. HEI's +10.09% print is the session's only thesis-relevant signal — defense aftermarket compounding exactly as underwritten, and I treat that as affirmation, not noise. The drags (GEV -3.01%, BE -2.87%, MP -2.63%) are single-day giveback on names opened yesterday into the physical-layer rotation; no named flow — not the Brookfield partnership, not the DoD NdPr stake — has changed, so I hold. The thesis is one day old and intact; nothing today moved the audit trail.

Regime NEUTRAL, cash 11.99%, 18 positions, 24 tickets emitted. Live macro digest reads neutral with extension override binding: QQQ +17.98% over 200d and wRSI 75.8 (SPY 71.6) confirm positioning is stretched, even as VIX 17.01 (-7.7% vs 200d) and HY OAS 2.72 signal complacency. The Gemini brief calls for risk_off at 25% cash, but live signal wins — Hormuz blockade is live (~27% seaborne crude disrupted, Brent $110+), April CPI re-accelerated to 3.8%, ISM Services Prices Paid stuck at cycle-high 70.7, and the Warsh Fed transition (May 15) has hawkish-balance-sheet implications with futures pricing <3% chance of a 2026 cut. 10Y Treasury at 4.622% mechanically discounts long-duration cash flows. Cash holds at neutral ceiling (15%) because the brief's tilt toward physical-layer energy/defense and away from duration-heavy biology and pure compute multiple-expansion is exactly the rotation the book needs — better to deploy into hedges and the named-flow mid-caps than sit in cash. Tail-risk hedges go max: CCJ (uranium producer), MP (rare-earth producer with DoD as largest shareholder), and SCCO (Mexican copper) — three commodity-producer slots vs §5.3 minimum of two. Six broken-thesis closes invoking unlock path B (positionBriefer verdict='broken'): CEG, VST, NOC, RTX, TMO, MRK. CEG and VST already trimmed to stubs; NOC (Sentinel margin breach, score 44), RTX (GTF overhang, score 56), TMO (Third Point full exit + bioprocess weakness, score 50), and MRK (Keytruda LOE bridge inadequate, score 53) all breach the 60-score floor with named invalidation triggers active. Capital redeploys into the brief's physical-layer thesis: open KTOS ($1.45B DoD hypersonic IDIQ), TLN (AWS 1,920 MW PPA through 2042), BE (Brookfield $5B AI DC fuel-cell partnership + Oracle deal), MP (DoD ~15% shareholder, 10-yr NdPr floor + magnet offtake), AVAV (Replicator drone pure-play per brief §7.1), HEI (defense aftermarket compounder), MU (memory infrastructure bottleneck — haiku flagged narrative shift to memory), ARGX (Belgian biology with intact pipeline). Add to TSM (only intact compute name, Jensen's $150B/yr Taiwan commitment) and CCJ (uranium anchor). Trim drift on NVDA, ASML, AVGO, NVO, LLY. Preserve VRTX as biology quality anchor. 18 positions, 15% cash, hedge slots maxed (CCJ, MP, SCCO). Flow read — Closing 6 broken-thesis names and rotating proceeds into named-flow mid-caps (KTOS, TLN, BE, MP, AVAV) — the brief's physical-layer thesis maps cleanly to specific signed contracts and DoD equity stak

Watch: 0 high · 6 med flags across 15 names. Regime NEUTRAL. Escalation pending.

Watch: 0 high · 8 med flags across 15 names. Regime NEUTRAL. Escalation pending.

Tape mildly green; book split, with MRK and power names leading against NVDA drag. MRK's +5.64% and the power pair VST/CEG up 4.94%/2.85% are the session's story for the Flagship — but per the May 11 thesis, all three are flagged broken and queued for hard trims, so today's strength is a better exit window, not a thesis revival. NVDA's -1.92% drag is noise against its intact-flow rating; I'm not reading deterioration there. The autopilot shadow scan on CEG and TMO confirms the book is still in trim-and-hold posture — nothing today shifts that, and regime remains neutral.

Watch: 2 high · 3 med flags across 15 names. Regime NEUTRAL. Escalation pending.